Current status of sonographically guided radiofrequency ablation techniques

Journal of Ultrasound in Medicine

Volumn 26, Issue 4, 2007, Pages 487-499

  Chiou, See Ying ^a,b   Liu, Ji Bin ^c   Needleman, Laurence ^c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Neoplasm; Radiofrequency ablation; Sonography; Thermal effect

Indexed keywords

COMPUTATIONAL METHODS; DATABASE SYSTEMS; ONCOLOGY; PATIENT MONITORING; THERMAL EFFECTS; TUMORS;

NEOPLASMS; RADIOFREQUENCY ABLATION; RENAL TUMORS; RFA TECHNOLOGY;

ULTRASONOGRAPHY;

ECHOGRAPHY; HUMAN; KIDNEY TUMOR; LIVER TUMOR; MEDLINE; OUTCOMES RESEARCH; PUBLICATION; RADIOFREQUENCY ABLATION; REVIEW; TREATMENT OUTCOME; TUMOR;

EID: 34047205018     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2007.26.4.487     Document Type: Review

References (97)

1. McGahan JP, Browning PD, Brock JM, Tesluk H. Hepatic ablation using radiofrequency electrocautery. Invest Radiol 1990; 25:267-274.
2. Rossi S, Fornari F, Buscarini L. Percutaneous ultrasound-guided radiofrequency electrocautery for the treatment small hepatocellular carcinoma. J Interv Radiol 1993; 8:97-103.
3. d'Arsonval A. Action physiologique des courants alternatifs. C R Soc Biol 1891; 43:283.
4. Jackman WM, Wang XZ, Friday KJ, et al. Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med 1991; 324:1605-1611.
5. Calkins H, Sousa J, el-Atassi R, et al. Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electro-physiologic test. N Engl J Med 1991; 324:1612-1618.
6. Goldberg SN, Gazelle GS, Solbiati L, Rittman WJ, Mueller PR. Radiofrequency tissue ablation increased lesion diameter with a perfusion electrode. Acad Radiol 1996; 3:636-644.
7. Siperstein AE, Gitomirski A. History and technological aspects of radiofrequency thermoablation. Cancer J 2000; 6(suppl 4):s293-s303.
8. Lencioni R, Cioni D, Goletti O, et al. Radiofrequency thermal ablation of liver tumors: state-of-the-art. Cancer J 2000;6(suppl4):s304-s315.
9. Liu JB, Goldberg BB, Merton DA, Rawool NM, Needleman L, Forsberg F. The role of contrast-enhanced sonography for radiofrequency ablation of liver tumors. J Ultrasound Med 2001; 20:517-523.
10. Cioni D, Lencioni R, Rossi S, et al. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power Doppler sonography to assess treatment outcome. AJR Am J Roentgenol 2001; 177:783-788.
11. Cedrone A, Pompili M, Sallustio G, Lorenzelli GP, Gasbarrini G, Rapaccini GL. Comparison between color power Doppler ultrasound with echo-enhancer and spiral computed tomography in the evaluation of hepatocellular carcinoma vascularization before and after ablation procedures. Am J Gastroenterol 2001; 96:1854-1859.
12. Curley SA. Radiofrequency ablation of malignant liver tumors. Ann Surg Oncol 2003; 10:338-347.
13. Ng KK, Poon RT. Radiofrequency ablation for malignant liver tumor. Surg Oncol 2005; 14:41-52.
14. Jaskolka JD, Asch MR, Kachura JR, et al. Needle tract seeding after radiofrequency ablation of hepatic tumors. J Vasc Interv Radiol 2005; 16:485-191.
15. Miyamoto N, Tsuji K, Sakurai Y, et al. Percutaneous radiofrequency ablation for unresectable large hepatic tumors during hepatic blood flow occlusion in four patients, Clin Radiol 2004; 59:812-818.
16. Yamasaki T, Kimura T, Kurokawa F, et al. Percutaneous radiofrequency ablation with cooled electrodes combined with hepatic arterial balloon occlusion in hepatocellular carcinoma. J Gastroenterol 2005; 40:171-178.
17. Cioni D, Lencioni R, Bartolozzi C. Percutaneous ablation of liver malignancies: imaging evaluation of treatment response. Eur J Ultrasound 2001; 13:73-93.
18. Catalano O, Lobianco R, Esposito M, Siani A. Hepatocellular carcinoma recurrence after percutaneous ablation therapy: helical CT patterns. Abdom Imaging 2001; 26:375-383.
19. Choi H, Loyer EM, DuBrow RA, et al. Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics 2001; 21(special issue): s41-s54.
20. Aliberti C, Soriani M, Tilli M, Benea G, De Giorgi U, Fiorentini G. Radiofrequency ablation of liver malignancies: MRI for evaluation of response. J Chemother 2004; 16(suppl5):79-81.
21. Rossi S, Stasi MD, Buscarini E, et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996; 167:759-768.
22. Solbiati L, Ierace T, Goldberg SN, et al. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 1997; 202:195-203.
23. Lau WY, Leung TW, Yu SC, Ho SK. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg 2003; 237:171-179.
24. Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000; 232:381-391.
25. Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000; 214:761-768.
26. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210:655-661.
27. Ikeda M, Okada S, Ueno H, Okusaka T, Kuriyama H. Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: a comparative study. Jpn J Clin Oncol 2001; 31:322-326.
28. Lencioni RA, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228:235-240.
29. Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129:122-130.
30. Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234:961-967.
31. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1000 cases. Cancer 2005; 103:1201-1209.
32. Raut CP, Izzo F, Marra P, et al. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol 2005; 12:616-628.
33. Montorsi M, Santambrogio R, Bianchi P, et al. Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis. J Gastrointest Surg 2005; 9:62-68.
34. Hong SN, Lee SY, Choi MS, et al. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 2005; 39:247-252.
35. Solbiati L, Goldberg SN, Ierace T, et al. Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology 1997; 205:367-373.
36. de Baere T, Elias D, Dromain C, et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol 2000; 175: 1619-1625.
37. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001; 221:159-166.
38. Oshowo A, Gillams AR, Lees WR, Taylor I. Radiofrequency ablation extends the scope of surgery in colorectal liver metastases. Eur J Surg Oncol 2003; 29:244-247.
39. Azzarello G, Lanteri R, Gresta S, et al. Thermic ablation with RF of liver metastases from colorectal cancer. Hepatogastroenterology 2003; 50(suppl):ccv-ccvii.
40. White TJ, Roy-Choudhury SH, Breen DJ, et al. Percutaneous radiofrequency ablation of colorectal hepatic metastases-initial experience: an adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases. Dig Surg 2004; 21:314-320.
41. Basdanis G, Michalopoulos A, Papadopoulos V, et al. Clinical short-term results of radiofrequency ablation in patients with liver metastases from colorectal cancer. Tech Coloproctol 2004; 8(suppl 1):s187-s189.
42. Livraghi T, Solbiati L, Meloni F, Irace T, Goldberg SN, Gazelle GS. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach." Cancer 2003; 97:3027-3035.
43. Oshowo A, Gillams A, Harrison E, Lees WR, Taylor I. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 2003; 90:1240-1243.
44. Evrard S, Becouarn Y, Fonck M, et al. Surgical treatment of liver metastases by radiofrequency ablation, resection, or in combination. Eur J Surg Oncol 2004; 30:399-106.
45. Elias D, Baton O, Sideris L, Matsuhisa T Pocard M, Lasser P. Local recurrences after intraoperative radiofrequency ablation of liver metastases: a comparative study with anatomic and wedge resections. Ann Surg Oncol 2004; 11 :500- 505.
46. Elias D, Baton O, Sideris L, et al. Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases. J Surg Oncol 2005; 90:36-42.
47. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239:818-827.
48. Wessels FJ, Schell SR. Radiofrequency ablation treatment of refractory carcinoid hepatic metastases. J Surg Res 2001; 95:8-12.
49. Berber E, Flesher N, Siperstein AE. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases. World J Surg 2002; 26:985-990.
50. Hellman P, Ladjevardi S, Skogseid B, Akerstrom G, Elvin A. Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors. World J Surg 2002; 26:1052-1056.
51. Elvin A, Skogseid B, Hellman P. Radiofrequency ablation of neuroendocrine liver metastases. Abdom Imaging 2005; 30:427-134.
52. Zlotta AR, Wildschutz T, Raviv G, et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol 1997; 11:251-238.
53. Pavlovich CP, Walther MM, Choyke PL, et al. Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol 2002; 167:10-15.
54. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 2003; 226:417-424.
55. Su LM, Jarrett TW, Chan DY, Kavoussi LR, Solomon SB. Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results. Urology 2003; 61(suppl 1): 26-33.
56. Mayo-Smith WW, Dupuy DE, Parikh PM, Pezzullo JA, Cronan JJ. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. AJR Am J Roentgenol 2003; 180:1503-1508.
57. Farrell MA, Charboneau WJ, DiMarco DS, et al. Imaging-guided radiofrequency ablation of solid renal tumors. AJR Am J Roentgenol 2003; 180:1509-1513.
58. Hwang JJ, Walther MM, Pautler SE, et al. Radio frequency ablation of small renal tumors: intermediate results. J Urol 2004; 171:1814-1818.
59. Neeman Z, Sarin S, Coleman J, Fojo T, Wood BJ. Radiofrequency ablation for tumor-related massive hematuria. J Vase Interv Radiol 2005; 16:417-421.
60. Rosenthal DI, Alexander A, Rosenberg AE, Springfield D. Ablation of osteoid osteoma with a percutaneously placed electrode: a new procedure. Radiology 1992; 183:29-33.
61. Woertler K, Vestring T, Boettner F, Winkelmann W, Heindel W, Lindner N. Osteoid osteoma: CT-guided percutaneous radiofrequency ablation and follow-up in 47 patients. J Vase Interv Radiol 2001; 12:717-722.
62. Rosenthal DI, Hornicek FJ, Torriani M, Gebhardt MC, Mankin HJ. Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology 2003; 229:171-175.
63. Erickson JK, Rosenthal DI, Zaleske DJ, Gebhardt MC, Cates JM. Primary treatment of chondroblastoma with percutaneous radio-frequency heat ablation: report of three cases. Radiology 2001; 221:463-468.
64. Callstrom MR, Charboneau JW, Goetz MR et al. Painful metastases involving bone: feasibility of percutaneous CT-and US-guided radio-frequency ablation. Radiology 2002; 224:87-97.
65. Goetz MP, Callstrom MR, Charboneau JW, et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 2004; 15:300-306.
66. Neeman Z, Wood BJ. Radiofrequency ablation beyond the liver. Tech Vase Interv Radiol 2002; 5:156-163.
67. Locklin JK, Mannes A, Berger A, Wood BJ. Palliation of soft tissue cancer pain with radiofrequency ablation. J Support Oncol 2004; 2:439-445.
68. Patti JW, Neeman Z, Wood BJ. Radiofrequency ablation of cancer-associated pain. J Pain 2002; 3:471-473.
69. Thanos L, Mylona S, Kalioras V, Pormoni M, Batakis N. Palliation of painful metastasis treated with radiofrequency thermal ablation. Cardiovasc Intervent Radiol 2005; 28:381-383.
70. Jeffrey SS, Birdwell RL, Ikeda DM, et al. Radiofrequency ablation of breast cancer: first report of an emerging technology. Arch Surg 1999; 134:1064-1068.
71. Izzo F, Thomas R, Delrio P, et al. Radiofrequency ablation in patients with primary breast carcinoma: a pilot study in 26 patients. Cancer 2001; 92:2036-2044.
72. Hayashi AH, Silver SF, van der Westhuizen NG, et al. Treatment of invasive breast carcinoma with ultrasound-guided radiofrequency ablation. Am J Surg 2003; 185:429-435.
73. Fornage BD, Sneige N, Ross MI, et al. Small (< or = 2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. Radiology 2004; 231:215-224.
74. Burak WE Jr, Agnese DM, Povoski SP, et al. Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical excision. Cancer 2003; 98:1369-1376.
75. Dupuy DE, Zagoria RJ, Akerley W, Mayo-Smith WW, Kavanagh PV, Safran H. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000; 174:57-59.
76. Herrera LJ, Fernando HC, Perry Y, et al. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg 2003; 125:929-937.
77. Gadaleta C, Mattioli V, Colucci G, et al. Radiofrequency ablation of 40 lung neoplasms: preliminary results. AJR Am J Roentgenol 2004; 183:361-368.
78. Yasui K, Kanazawa S, Sano Y, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology 2004; 231:850-857.
79. Akeboshi M, Yamakado K, Nakatsuka A, et al. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vase Interv Radiol 2004; 15:463-470.
80. Steinke K, Glenn D, King J, et al. Percutaneous imaging-guided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up. Ann Surg Oncol 2004; 11:207-212.
81. Belfiore G, Moggio G, Tedeschi E, et al. CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer-a preliminary report of 33 patients. AJR Am J Roentgenol 2004; 183:1003-1011.
82. Fernando HC, De Hoyos A, Landreneau RJ, et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 2005; 129:639-644.
83. Nguyen CL, Scott WJ, Young NA, Rader T, Giles LR, Goldberg M. Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study. Chest 2005; 128:3507-3511.
84. Wood BJ, Abraham J, Hvizda JL, Alexander HR, Fojo T. Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 2003; 97:554-560.
85. Mayo-Smith WW, Dupuy DE. Adrenal neoplasms: CT-guided radiofrequency ablation-preliminary results. Radiology 2004; 231:225-230.
86. Wood BJ, Bates S. Radiofrequency thermal ablation of a splenic metastasis. J Vase Interv Radiol 2001; 12:261-263.
87. Marangio A, Prati U, Luinetti O, Brunetti E, Felice C. Radiofrequency ablation of colorectal splenic metastasis. AJR Am J Roentgenol 2002; 178:1481-1482.
88. Leveillee RJ, Hoey MF, Hulbert JC, Muller R Lee D, Jesserun J. Enhanced radiofrequency ablation of canine prostate utilizing a liquid conductor: the virtual electrode. J Endourol 1996; 10:5-11.
89. Liu JB, Merton DA, Wansaicheong G, et al. Contrast enhanced ultrasound for radio frequency ablation of canine prostates: initial results. J Urol 2006; 176:1654-1660.
90. Goldberg SN, Mallery S, Gazelle GS, Brugge WR. EUS-guided radiofrequency ablation in the pancreas: results in a porcine model. Gastrointest Endosc 1999; 50:392-401.
91. Parrent AG. Stereotactic radiofrequency ablation for the treatment of gelastic seizures associated with hypothalamic hamartoma: case report. J Neurosurg 1999; 91:881-884.
92. Anzai Y, Lufkin R, DeSalles A, Hamilton DR, Farahani K, Black KL. Preliminary experience with MR-guided thermal ablation of brain tumors. AJNR Am J Neuroradiol 1995; 16:39-48.
93. Dupuy DE, Monchik JM, Decrea C, Pisharodi L. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery 2001; 130:971-977.
94. Hiraki T, Yasui K, Mimura H, et al. Radiofrequency ablation of metastatic mediastinal lymph nodes during cooling and temperature monitoring of the tracheal mucosa to prevent thermal tracheal damage: initial experience. Radiology 2005; 237:1068-1074.
95. Ohhigashi S, Watanabe F. Radiofrequency ablation is useful for selected cases of pelvic recurrence of rectal carcinoma. Tech Coloproctol 2003; 7:185-191.
96. Stang A, von Seydewitz CU, Celebcioglu S, Keles H, Hagenmuller F, Braumann D. Ultrasound-guided radiofrequency ablation: a new treatment option after failure to stop severe acute upper gastrointestinal tumor bleeding using endoscopic techniques. Endoscopy 2004; 36:558-561.
97. Campbell C, Soulen MC, Horii SC, Seigelman ES, Rubesin SE, Vaughn DJ. Transrectal radiofrequency ablation for pelvic recurrence of bladder cancer: case report and review of complications. J Vase Interv Radiol 2005; 16:1027-1032.